HCmed Innovations Co., Ltd. Stock Price

TPEX:6934 Community·NT$2.2b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6934 Share Price Performance

NT$68.70

-19.30 (-21.93%)

NT$68.70

-19.30 (-21.93%)

NT$68.70

Thu, 6 Nov 25

Share PriceNT$68.70

6934 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks

1 Reward

View Full Analysis

HCmed Innovations Co., Ltd. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -3.28
: 62.74%
: -80.13%
: 15.0%

View Full Analysis

About 6934

Founded: 2014
Employees: n/a
CEO: Jason Cheng
WebsiteView website: www.hcmed-inno.com

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides contract development and manufacturing organization services. The company was founded in 2014 and is headquartered in Taipei, Taiwan.